Discover free eBooks, guides and med spa templates on our new resources page

Billing Codes

CPT Code 45385: Colonoscopy with Removal of Tumor(s), Polyp(s), or Lesion(s) by Snare Technique

Key Takeaways

Key Takeaways

CPT 45385 applies when polyps are removed using snare technique during colonoscopy

Screening procedures convert to diagnostic when polyps are discovered and removed

Modifier 33 applies to preventive screening colonoscopies under Medicare coverage

Documentation must specify snare technique, polyp location, and electrocautery use

Medicare reimbursement averages $350-450 depending on facility and geographic location

Introduction to CPT Code 45385

CPT code 45385 represents colonoscopy with removal of tumor(s), polyp(s), or other lesion(s) by snare technique. When a gastroenterologist identifies and removes a polyp during a colonoscopy using a heated wire loop or electrocautery snare, this code applies. The procedure differs from simple diagnostic colonoscopy because it involves therapeutic intervention beyond visual examination.

The American Medical Association maintains this code as part of the endoscopy procedures category. Most gastroenterology practices bill CPT 45385 multiple times weekly because colorectal polyps appear in roughly 30-40% of screening colonoscopies among average-risk adults over age 50. Understanding when to apply this code versus related colonoscopy codes prevents claim denials and ensures appropriate reimbursement.

CPT 45385 Code Definition and Clinical Application

According to the AMA’s CPT code set, CPT 45385 describes a flexible colonoscopy procedure where the physician advances the endoscope beyond the splenic flexure and removes one or more lesions using snare technique. The snare itself consists of a wire loop that tightens around the polyp base, often combined with electrocautery to cauterise tissue and prevent bleeding.

The Centers for Medicare & Medicaid Services recognises this as a moderate-complexity procedure. Snare polypectomy requires more skill than diagnostic colonoscopy but less than endoscopic mucosal resection. The technique works best for sessile or pedunculated polyps measuring 5-20mm in diameter. Flat lesions under 5mm typically undergo cold forceps removal instead, which falls under different coding.

When CPT 45385 Applies

CPT code 45385 applies in these clinical scenarios: a screening colonoscopy transitions to therapeutic when polyps appear, a diagnostic colonoscopy follows up on abnormal imaging findings and removes identified lesions, or a surveillance colonoscopy in patients with prior polyp history removes new growths. The code covers removal of adenomatous polyps, hyperplastic polyps, serrated lesions, and benign tumours accessible via snare.

The technique specifies snare use. If the physician removes polyps via hot biopsy forceps, cold forceps, or ablation methods, different codes apply. A single CPT 45385 code covers removal of multiple polyps during the same session when all use snare technique. The number of polyps removed does not affect the base code-additional units or modifiers address multiple lesions in specific billing contexts.

Screening to Diagnostic Conversion

Medicare and most commercial payers mandate coding conversion when a screening colonoscopy yields polyp removal. The procedure begins as preventive screening (G0105 or G0121 for Medicare patients, or CPT 45378 with modifier 33 for commercial payers). Once the gastroenterologist identifies and removes a polyp, the procedure converts to diagnostic. Billing then shifts to CPT 45385 without the screening modifier.

This conversion affects patient cost-sharing. Preventive screenings under the Affordable Care Act carry no patient responsibility. When the procedure converts to diagnostic, deductibles and copayments apply. Claims management software with built-in conversion logic helps practices navigate this coding shift and communicate cost implications to patients before the procedure.

Documentation Requirements for CPT Code 45385

Complete documentation prevents claim denials and supports medical necessity. The operative report must specify several elements: the endoscope reached beyond the splenic flexure, the physician visualised polyps or lesions, snare technique was employed (including electrocautery settings if applicable), and each lesion’s anatomical location within the colon. Size estimations, morphology descriptions (sessile, pedunculated, flat), and tissue pathology plans strengthen the record.

Medicare and commercial payers audit colonoscopy claims frequently. Incomplete documentation triggers requests for medical records. A phrase like “polyp removed” without technique specification fails to justify CPT 45385. The report should state “cold snare polypectomy” or “hot snare polypectomy with electrocautery” to differentiate from forceps-based removal covered under different codes.

Required Documentation Elements

Every CPT 45385 procedure note should document: indication for colonoscopy (screening, surveillance, diagnostic), bowel preparation quality using the Boston Bowel Preparation Scale or similar tool, endoscope insertion depth confirmation (cecum reached and verified via landmarks), withdrawal time, number and location of polyps (ascending colon, transverse colon, descending colon, sigmoid, rectum), snare type and size, electrocautery settings if hot snare used, retrieval method for pathology specimens, and post-polypectomy inspection for bleeding or perforation.

Pathology correlation matters. The operative note should reference which specimens were sent for histologic analysis. If multiple polyps were removed, each specimen container must link to its anatomical source. This traceability supports coding accuracy when pathology reveals advanced adenomas requiring shortened surveillance intervals.

Common Documentation Deficiencies

Three documentation gaps cause most denials: technique ambiguity (not specifying snare versus forceps), anatomical vagueness (stating “colon polyp” without segment identification), and missing medical necessity justification. Payers expect clear indication statements. “Screening colonoscopy” alone suffices for initial procedures. For surveillance cases, reference prior polyp findings or family history of colorectal cancer.

Templates with pre-populated fields help ensure complete documentation. AI-powered clinical documentation tools can auto-generate structured operative notes from voice dictation, reducing documentation time while maintaining coding compliance. These systems prompt clinicians to capture all required elements before finalising the note.

Pro Tip

Audit 10 random colonoscopy notes monthly for CPT 45385 billing. Verify each includes snare technique specification, polyp location, and electrocautery details. Consistent documentation patterns reduce denial rates by 25-30% within six months of implementing focused reviews.

CPT 45385 Billing Guidelines and Modifiers

Medicare reimburses CPT 45385 under the Physician Fee Schedule based on relative value units. National payment averages range from $350 to $450 for the professional component, with higher reimbursement in hospital outpatient departments due to facility fees. Geographic adjustments via the Geographic Practice Cost Index shift these amounts regionally.

Billing a single unit of CPT 45385 covers all polyps removed via snare during one session. Multiple polyps do not justify multiple units unless separate insurance policies or unusual circumstances apply. Modifier 59 may apply when distinct polyps are removed using different techniques during the same encounter-for example, one polyp via snare (CPT 45385) and another via hot biopsy forceps (CPT 45384).

Modifier 33 for Preventive Services

Modifier 33 identifies preventive services under the Affordable Care Act. Commercial payers use this modifier on screening colonoscopies to waive patient cost-sharing. When CPT 45385 represents a converted screening (polyp found during preventive exam), do not append modifier 33. The code conversion itself signals the shift from preventive to diagnostic, triggering standard deductible and copayment rules.

Medicare patients follow different logic. Medicare uses G-codes (G0105, G0121) for screening colonoscopies rather than CPT codes with modifiers. When a screening converts due to polyp removal, bill CPT 45385 with modifier PT (colorectal cancer screening test converted to diagnostic test). This modifier preserves some cost-sharing protections for the patient while signalling the diagnostic nature of the completed procedure.

National Correct Coding Initiative Edits

The National Correct Coding Initiative prohibits billing multiple colonoscopy codes during the same session unless medical necessity justifies separate procedures. CPT 45385 bundles with diagnostic colonoscopy (CPT 45378)-you cannot bill both. If biopsy forceps and snare techniques both occurred, report only the higher-valued code (CPT 45385) unless modifiers 59 or XS demonstrate distinct procedural sessions.

Some payers allow CPT 45385 with CPT 45381 (submucosal injection) when injection facilitates snare removal of large sessile polyps. However, routine saline lifting before snare polypectomy does not meet this threshold. Documentation must justify the injection as a distinct, medically necessary step beyond standard snare preparation.

Automate CPT Code Validation Before Claim Submission

Pabau's claims management system validates CPT 45385 coding rules, flags missing modifiers, and checks NCCI edits in real-time. Reduce denials and accelerate reimbursement with pre-submission claim scrubbing.

Pabau claims management dashboard

Reimbursement Rates and Geographic Variations for CPT 45385

Medicare payment for CPT code 45385 varies by practice location and service setting. The 2026 national average work RVU (relative value unit) for CPT 45385 is 4.74, with total non-facility RVUs around 8.12. After applying the Medicare conversion factor ($33.29 in 2026), this translates to approximately $270 for the physician’s work in an office-based setting. Facility-based procedures receive lower professional fees because the hospital bills separately for facility costs.

Geographic adjustments shift these baselines significantly. High-cost areas like Manhattan or San Francisco see reimbursement 30-40% above the national average due to elevated practice expense indices. Rural areas with lower overhead costs receive proportionally reduced payments. Commercial payers typically reimburse 150-200% of Medicare rates, bringing CPT 45385 payments to $400-540 in most markets.

Commercial Payer Contracts

Negotiating CPT 45385 rates with commercial payers requires understanding relative value scales. Many contracts reference Medicare rates as a baseline multiplier-for example, “Medicare plus 80%” or “200% of Medicare allowable.” For a procedure reimbursed at $270 by Medicare, 180% yields $486. However, some payers cap individual procedure rates regardless of percentage agreements, particularly for high-volume codes like colonoscopy CPT codes.

Bundled payment models increasingly affect colonoscopy reimbursement. Accountable care organisations and value-based contracts may include CPT 45385 in colorectal cancer screening episode payments. Under these models, practices receive a fixed amount per screening cycle rather than fee-for-service payment per procedure. Understanding your contract structure determines whether individual code optimization matters or episode-level cost efficiency drives revenue.

Tracking Procedure-Level Profitability

Gastroenterology practices should monitor CPT 45385 profitability by calculating total reimbursement minus direct costs. Direct costs include scope sterilisation, single-use snares (averaging $15-30 per unit), pathology fees, and staff time. A colonoscopy generating $450 in revenue with $120 in direct costs and $85 in allocated overhead yields $245 in contribution margin.

Comparing CPT 45385 margins across payers reveals contract performance gaps. If Medicare pays $270 and Commercial Payer A pays $425, but Commercial Payer B pays only $310, renegotiation targets become clear. Practice dashboards that aggregate procedure-level reimbursement by payer type enable data-driven contract discussions during renewal cycles.

Common CPT 45385 Coding Errors and How to Avoid Them

Three coding errors dominate CPT 45385 denials: confusing snare technique with forceps biopsy, billing CPT 45385 alongside diagnostic colonoscopy without appropriate modifiers, and applying screening modifiers after polyp removal. Each error stems from misunderstanding how payer policies distinguish procedure types and billing hierarchies.

Snare versus forceps distinction trips up many coders. Hot biopsy forceps removal of diminutive polyps (under 5mm) codes to CPT 45384, not CPT 45385. The operative note must specify snare technique explicitly. If the physician used cold forceps for small polyps and snare for larger ones, bill only CPT 45385-the higher-valued code absorbs the lesser procedure under NCCI bundling rules.

CPT 45385 vs CPT 45380 Coding Confusion

CPT 45380 covers colonoscopy with biopsy, while CPT 45385 covers polyp removal via snare. The distinction matters clinically and financially. Biopsy typically involves forceps sampling of tissue without complete lesion removal. Snare polypectomy removes the entire polyp. If the operative note describes “polyp biopsied and removed,” clarify with the physician whether full removal occurred (CPT 45385) or sampling preceded planned follow-up removal (CPT 45380).

Some encounters involve both biopsy of suspicious tissue separate from polyp removal. For example, the gastroenterologist biopsies an ulcerated area in the ascending colon and removes a polyp in the sigmoid via snare. Bill CPT 45385 for the snare polypectomy and CPT 45380 with modifier 59 if documentation supports distinct lesions and techniques. Modifier 59 demonstrates the biopsy targeted a different site and served a different diagnostic purpose.

Screening to Diagnostic Conversion Errors

Billing screening colonoscopy codes (G0105, G0121, or CPT 45378 with modifier 33) when polyps were removed triggers automatic denials. The moment tissue removal occurs, the procedure converts to therapeutic. Medicare requires CPT 45385 with modifier PT for converted screenings. Commercial payers typically accept CPT 45385 without screening modifiers, applying standard cost-sharing rules.

Front-desk staff should inform patients before colonoscopy that polyp discovery shifts the procedure from preventive to diagnostic for billing purposes. This transparency prevents surprise bills and patient complaints. Patient portals with pre-procedure education modules can deliver this message consistently, documenting patient acknowledgment of potential cost-sharing changes.

Pro Tip

Run quarterly audits comparing CPT 45385 claims against pathology reports. Verify each billed snare polypectomy corresponds to a pathology specimen documenting tissue removal. Mismatches indicate potential upcoding or documentation gaps requiring immediate correction.

Understanding the full colonoscopy code family helps coders select the most accurate option. CPT 45378 represents diagnostic colonoscopy with visualization only-no biopsy or removal. This code applies when the examination finds no abnormalities requiring intervention or when the gastroenterologist cannot reach the cecum due to patient factors like severe stenosis or poor preparation.

CPT 45380 covers colonoscopy with biopsy using forceps. If the physician samples tissue from multiple sites without removing entire lesions, this code applies. CPT 45384 describes removal of tumors or polyps via hot biopsy forceps, distinct from snare technique. CPT 45385 sits hierarchically above these codes because snare polypectomy typically addresses larger lesions requiring more skill and time.

CPT 45385 vs CPT 45390 (Endoscopic Mucosal Resection)

CPT 45390 represents endoscopic mucosal resection (EMR), a more complex intervention than standard snare polypectomy. EMR involves submucosal lifting fluid injection followed by piecemeal resection of large flat lesions exceeding 2cm. The technique requires advanced training and carries higher perforation risk. Medicare reimburses CPT 45390 at roughly 50% more than CPT 45385 due to increased complexity.

Distinguishing CPT 45385 from CPT 45390 depends on lesion size, morphology, and technique documentation. A 3cm sessile polyp removed in multiple pieces with submucosal injection qualifies for CPT 45390. A 1.5cm pedunculated polyp removed intact via snare fits CPT 45385. Operative notes must detail these elements to support the selected code. Ambiguous documentation defaults to the lower-valued code under payer adjudication rules.

Multiple Polyp Removal Scenarios

When a colonoscopy yields removal of multiple polyps all via snare technique, bill one unit of CPT 45385 regardless of polyp count. The code descriptor’s plural “polyps” covers this scenario. Do not bill multiple units unless separate insurance policies or bilateral procedures apply (colonoscopy is unilateral, so bilateral modifiers never apply here).

If the gastroenterologist removes some polyps via snare and others via forceps, prioritize CPT 45385 as the primary code. Add modifier 59 to CPT 45380 or CPT 45384 only if documentation demonstrates distinct lesions in separate colon segments with different removal indications. Routine removal of multiple polyps using varied techniques on an opportunistic basis does not meet the “distinct procedural service” threshold for modifier 59 application.

Optimizing CPT 45385 Billing Workflow

Efficient billing workflows reduce claim lag time and denial rates. Integrate coding into the procedure day workflow rather than batching claims weekly. Immediate post-procedure coding while clinical details remain fresh improves accuracy. Many endoscopy suites use real-time documentation systems where the nurse records findings during the procedure, enabling same-day charge capture.

Automated coding suggestions based on operative note keywords reduce manual code selection errors. When the documentation mentions “snare” and “polyp,” the system auto-suggests CPT 45385 with a prompt to verify snare technique was used. Workflow automation can route these suggested codes to certified coders for final review, maintaining accuracy while accelerating throughput.

Pre-Submission Claim Scrubbing

Claim scrubbing software validates CPT 45385 submissions against payer-specific rules before transmission. The system checks for missing modifiers, NCCI edit violations, and LCD (local coverage determination) compliance. For example, if a Medicare Advantage plan requires prior authorization for therapeutic colonoscopies, the scrubber flags missing authorization numbers before claim submission.

Scrubbing reduces the clean claim rate from 85-90% (industry average without scrubbing) to 95-98% when implemented correctly. The key lies in keeping rule sets current as payers update policies quarterly. Subscribe to payer listservs announcing policy changes, and update your scrubbing rules within 30 days of effective dates. Delayed updates allow non-compliant claims to slip through, generating back-end denials that require appeals.

Denial Management and Appeals

Track CPT 45385 denial patterns by reason code. Common denials include: “documentation does not support medical necessity” (reason code CO-50), “NCCI edit-service included in another procedure” (reason code CO-97), and “missing or invalid modifier” (reason code CO-4). Addressing the top three denial reasons eliminates 70-80% of rework.

Build appeal templates for recurring denial scenarios. For medical necessity denials, the template references AMA CPT descriptor language, attaches the operative note highlighting snare technique and polyp location, and cites clinical guidelines supporting polypectomy for the identified lesion type. Standardized appeals reduce response time from 14 days to 3-5 days while maintaining approval rates above 75% for legitimate claims.

Expert Picks

Expert Picks

Need a structured claims tracking system? Claims Management Software provides real-time visibility into CPT 45385 submission status, denial reasons, and payer-specific reimbursement patterns.

Looking to streamline gastroenterology workflows? Automated Workflows Software guides staff through colonoscopy billing steps, from coding validation to claim submission and follow-up.

Want to reduce clinical documentation time? Echo AI generates structured operative notes from voice dictation, capturing required CPT 45385 documentation elements automatically.

Conclusion

CPT code 45385 represents a cornerstone procedure in gastroenterology billing, covering colonoscopy with snare polypectomy for tumor, polyp, or lesion removal. Accurate coding requires clear documentation of snare technique, polyp location, and medical necessity. Understanding screening-to-diagnostic conversion rules, modifier application, and NCCI edits prevents the majority of claim denials.

Reimbursement optimization depends on tracking procedure-level profitability, negotiating commercial contracts with data, and implementing workflow automation that validates coding accuracy before submission. Gastroenterology practices that master CPT 45385 billing mechanics improve revenue cycle efficiency while maintaining compliance with payer policies and AMA coding standards.

Frequently Asked Questions

How does CPT 45385 differ from CPT 45378?

CPT 45378 covers diagnostic colonoscopy with visualization only, while CPT 45385 includes polyp removal via snare technique. The key distinction is therapeutic intervention-45385 applies when tissue is removed using a wire loop or electrocautery snare, whereas 45378 applies when no intervention occurs beyond examination.

Can I bill multiple units of CPT 45385 for removing multiple polyps?

No. CPT 45385 covers all polyps removed via snare technique during a single session. The code descriptor uses the plural “polyps,” indicating one unit applies regardless of how many lesions are removed. Multiple units are not appropriate unless separate procedures occur under distinct circumstances.

When should I use modifier 33 with CPT 45385?

Do not use modifier 33 with CPT 45385. Modifier 33 applies to screening procedures before intervention. When polyps are removed, the procedure converts from screening to diagnostic. Medicare requires modifier PT for converted screenings, while commercial payers typically accept CPT 45385 without screening modifiers.

What documentation must accompany CPT 45385 billing?

Required documentation includes indication for colonoscopy, confirmation of cecal intubation, snare technique specification (hot or cold), anatomical location of each polyp, size estimation, morphology description, electrocautery settings if applicable, and pathology specimen tracking. Missing any element increases denial risk.

How does screening colonoscopy conversion affect patient cost-sharing?

Preventive screening colonoscopies under the ACA carry no patient cost-sharing. When polyp removal converts the procedure to diagnostic, standard deductibles and copayments apply. Inform patients before the procedure that polyp discovery may shift billing from preventive to diagnostic, affecting out-of-pocket costs.

What is the average Medicare reimbursement for CPT 45385 in 2026?

Medicare reimburses CPT 45385 at approximately $270 nationally for office-based settings, based on 4.74 work RVUs and the 2026 conversion factor of $33.29. Facility-based procedures receive lower professional fees. Geographic adjustments shift these amounts 30-40% higher in high-cost areas.

×